Insider Transactions in Q3 2021 at Asensus Surgical, Inc. (ASXC)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 22
2021
|
Elizabeth Kwo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
54,201
+50.0%
|
-
|
Jul 22
2021
|
Kevin J Hobert Director |
BUY
Exercise of conversion of derivative security
|
Direct |
54,201
+50.0%
|
-
|
Jul 03
2021
|
Anthony C. J. Fernando President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,146
-0.35%
|
$2,292
$2.89 P/Share
|
Jul 03
2021
|
Anthony C. J. Fernando President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,565
+0.78%
|
-
|
Jul 01
2021
|
Rampertab Shameze EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,558
-27.35%
|
$9,116
$2.93 P/Share
|
Jul 01
2021
|
Rampertab Shameze EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+50.0%
|
-
|
Jul 01
2021
|
Jane Ph D Hsiao Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,231
+7.98%
|
-
|
Jul 01
2021
|
Paul A Laviolette Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,846
+50.0%
|
-
|
Jul 01
2021
|
David Bruce Milne Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,231
+10.66%
|
-
|
Jul 01
2021
|
Richard C Pfenniger Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,846
+12.22%
|
-
|
Jul 01
2021
|
William N Starling Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,846
+25.31%
|
-
|